![The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell lines]()
The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell linesChow, Kai Uwe; Nowak, Daniel; Trepohl, Bettina; Hochmuth, Simone; Schneider, Bernd; Hoelzer, Dieter; Mitrou, Paris S.; Bergmann, Lothar; Ottmann, Oliver Gerhard; Boehrer, Simone · Leukemia & Lymphoma · 2007